Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2021 / Cilt: 55 - Sayı: 1

Incidence, Histopathological Features and Differential Diagnosis of Cutaneous Graft Versus Host Disease in Allogeneic Bone Marrow Transplantation

Sayfa
68–75
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Dermatologi- cal early recognition of the disease; histopathological evaluation and verification with differential diagnosis plays a key role in preventing patient morbidity and mortality.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Hematopoietic stem cell transplantation by allogeneic bone marrow transplantation is a method used in the treat- ment of various genetic, immunological disorders, hematologic and solid organ malignancies.
📊
Temel Bulgular & Veri:Methods: The pathology slides of allogeneic bone marrow transplantation patients who were diagnosed as graft versus Host Disease in our pathology department between January 2015 and January 2019 were re-evaluated.
💡
Sonuç & Katkı:Dermatologi- cal early recognition of the disease; histopathological evaluation and verification with differential diagnosis plays a key role in preventing patient morbidity and mortality.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Hematopoietic stem cell transplantation by allogeneic bone marrow transplantation is a method used in the treat- ment of various genetic, immunological disorders, hematologic and solid organ malignancies. Graft versus Host Disease is one of the major and fatal complications of allogeneic bone marrow transplantation. It is a systemic disease affecting five main areas: skin, gastrointestinal tract, liver, lung and hematopoietic system. Diagnosis of cutaneous Graft versus Host Disease is made by the correlation between clinical and histopathological findings of the patient. The present study aims to investigate the incidence of cutaneous graft versus Host Disease in allogeneic bone marrow transplantation patients in our center, to discuss the histopatho- logical features and differential diagnosis of cutaneous graft versus Host Disease in the light of the literature. Methods: The pathology slides of allogeneic bone marrow transplantation patients who were diagnosed as graft versus Host Disease in our pathology department between January 2015 and January 2019 were re-evaluated. Epidermal and dermal histo- morphological findings of the disease were classified; the patients’ clinical and demographic information was obtained from the files. The incidence of cutaneous Graft versusHost Disease was calculated. Results: In our center, between January 2015 and January 2019, 273 pediatric and 100 adult patients underwent allogeneic and 181 autologous bone marrow transplantation. Twenty-three patients who underwent allogeneic bone marrow transplantation had cutaneous Graft versus Host Disease whereas and 21 patients had gastrointestinal Graft versus Host Disease. The incidence of cutaneous and gastrointestinal Graft versus Host Disease was 16.1% whereas the incidence of cutaneous Graft versus Host Disease was 8.42%. The most common clinical differential diagnosis of cutaneous Graft versus Host Disease was drug reaction (74%). The most common epidermal histomorphologic finding in our cases was keratinocyte necrosis (87%). In our cases, the most common epidermal histomorphologic finding was keratinocyte necrosis (87%). This was followed by vacuolar degeneration in basal kerati- nocytes (63%), acanthosis and spongiosis (61%), respectively. The most common finding in the dermis was pigment incontinence (59%). Of the patients with Graft versus Host Disease, 56% had transplantation from unrelated donors, whereas 44% of them had transplantation from their relatives. Conclusion: Cutaneous Graft versus Host Disease is a common complication of allogeneic hematopoietic stem cell transplanta- tion. It is associated with high mortality rates and has a significant negative impact on the patient's quality of life. Dermatologi- cal early recognition of the disease; histopathological evaluation and verification with differential diagnosis plays a key role in preventing patient morbidity and mortality.

🔖

Bu Makaleye Atıf Yap

HACİSALİHOGLU, U. P., SAHİN, D. (2021). Incidence, Histopathological Features and Differential Diagnosis of Cutaneous Graft Versus Host Disease in Allogeneic Bone Marrow Transplantation. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 1, 68–75. https://ajindex.com/articles/402862

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Villarreal CD, Alanis JC, Pérez JC, Candiani JO. Cutaneous graft- versus-host disease after hematopoietic stem cell transplant - a review. An Bras Dermatol 2016;91:336–43
  2. Strong Rodrigues K, Oliveira-Ribeiro C, de Abreu Fiuza Gomes S, Knobler R. Cutaneous graft-versus-host disease: diagnosis and treatment. Am J Clin Dermatol 2018;19:33–50
  3. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development proj- ect on criteria for clinical trials in chronic graft-versus-host dis- ease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11:945–56
  4. Friedman KJ, LeBoit PE, Farmer ER. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation. Arch Derma- tol 1988;124:688–91
  5. Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, et al. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant 2015;21:589–603
  6. Yanamandra U, Nahar Saikia U, Prakash G, Khadwal A, Malhotra P, Varma S. Skin GVHD mimicking betadine rash in a post allogeneic transplant patient. Indian J Hematol Blood Transfus 2017;33:427– 30
  7. Kumar AJ, Kim S, Hemmer MT, Arora M, Spellman SR, Pidala JA, et al. Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants. Blood Adv 2018;2:1022–31
  8. Nishiwaki S, Terakura S, Ito M, Goto T, Seto A, Watanabe K, et al. Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft- versus-host disease. Blood 2009;114:3113–6
  9. Santos E Sousa P, Bennett CL, Chakraverty R. Unraveling the mechanisms of cutaneous graft-versus-host disease. Front Im- munol 2018;9:963
  10. Byun HJ, Yang JI, Kim BK, Cho KH. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions. J Am Acad Dermatol 2011;65:726–32
  11. Prieto-Torres L, Boggio F, Gruber-Wackernagel A, Cerroni L. Nodu- lar sclerodermatous chronic cutaneous graft-versus-host disease (GvHD): a new clinicopathological variant of cutaneous sclero- dermatous GvHD resembling nodular/keloidal scleroderma. Am J Dermatopathol 2017;39:910–3
  12. Gökdemir G, Kıvanç-Altunay İ, Göksu F, Köşlü A. Clinical course of bullous erythema multiforme receiving high-dose corticosteroid treatment. M